Solmaz Sahebjam

12PUBLICATIONS
71CO-AUTHORS
Molecular targetsHaematological tumoursCancer diagnosisTumour immunologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 02, 2026
A phase 2 study of abemaciclib in patients with brain metastases secondary to non-small cell lung cancer or melanoma.

Solmaz Sahebjam, Danielle A Bazer, Emilie Le Rhun

|Sep 01, 2025
Phase IB study of Avelumab and whole brain radiotherapy in patients with leptomeningeal disease from solid tumors: Results and molecular analyses.

Yolanda Piña, Vincent Law, Solmaz Sahebjam

|Jun 23, 2025
Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee.

Jennifer Dent, Micaella Jorge, Nora Sobrevilla

|Jun 19, 2025
First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors.

Timothy A Yap, Olivier Rixe, Capucine Baldini

|Apr 25, 2025
Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patient with brain metastases.

Carey K Anders, Amanda E D Van Swearingen, Josh Neman

|Mar 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas.

Solmaz Sahebjam, Raju R Raval, Peter A Forsyth

Pageof 2

Frequent Collaborators

2 joint publications

Dung-Tsa Chen

1 joint publications

Kirit Singh

1 joint publications

Ian F Parney

1 joint publications

Nader Sanai